Annotating MYC oncogene status with (89)Zr-transferrin imaging

A non-invasive technology that quantitatively measures the activity of oncogenic signaling pathways could broadly impact cancer diagnosis and treatment using targeted therapies. Here we describe the development of (89)Zr-desferrioxamine transferrin ((89)Zr-Tf), a novel positron emission tomography (...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, Jason P., Evans, Michael J., Rice, Samuel L., Wongvipat, John, Sawyers, Charles L., Lewis, Jason S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521603/
https://www.ncbi.nlm.nih.gov/pubmed/23001181
http://dx.doi.org/10.1038/nm.2935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521603/
https://www.ncbi.nlm.nih.gov/pubmed/23001181
http://dx.doi.org/10.1038/nm.2935

Ejemplares similares